United States (USA) Anti-Snoring Devices Market Overview, 2031

In the last twenty years, the United States has experienced consistent growth in sleep health solutions driven by awareness, progressing faster than many regional markets due to the nation’s early embrace of consumer wellness technologies and a competitive culture in medical device innovation. The rationale behind the usage of anti-snoring devices in the U.S. arises from an increasing emphasis on preventive health, better sleep quality, and managing mild to moderate breathing issues without resorting to invasive treatments. Contemporary anti-snoring devices were launched relatively early within the U.S. healthcare and consumer markets, gaining traction as designs advanced and consumers, from adults with habitual snoring to those experiencing lifestyle-related airway obstructions, looked for effective and accessible remedies. These anti-snoring devices work by employing various methods such as stabilizing airways, advancing the jaw, dilating the nasal passages, and detecting vibrations for corrective feedback, all aimed at minimizing tissue collapse or restricting airflow during sleep. Their effectiveness is evident through enhanced airflow, fewer nighttime disturbances, and improved rest, providing clear and measurable daily benefits. Innovations in U.S. engineering, including improvements in biocompatible materials, smart-sensor technology, and customized ergonomic designs, have largely improved both comfort and efficiency. Ongoing research and development initiatives continue to enhance product reliability, fostering solutions that meet contemporary wellness expectations. Regulatory standards and certifications like FDA approval, material safety compliance, and clinical testing regulations offer consumers assurance by guaranteeing that U.S. products adhere to established safety, durability, and physiological efficacy standards.

According to the research report, "US Anti-Snoring Overview, 2031," published by Bonafide Research, the US Anti-Snoring market was valued at more than US 583.23 Million in 2025.The U.S. maintains a strong market development, built on its history and focus on innovation, as changing trends in sleep wellness impact the use of devices in both clinical and consumer sectors. Recent innovations encompass features for digital health tracking, improved designs for oral appliances thanks to cutting-edge CAD/CAM technology, and the rise of smart devices connected to apps that can monitor snoring incidents and modify settings on the spot. , the sector has witnessed greater collaboration with distribution networks, sleep consultations conducted via telehealth, and wider insurance consideration facilitating access to medically approved products. Leading firms in America in this domain include those that create devices for mandibular advancement, nasal airflow enhancement, positional therapy aids, and smart tools utilizing sensors, each catering to different user preferences, from economical options to advanced, personalized technologies. Their marketing tactics frequently focus on maximizing comfort, ensuring durability over time, and compliance with U.S. regulatory standards, delivering solutions in line with both health requirements and user lifestyles. The market in the U.S. is bolstered by increasing consumer understanding of the effects of sleep-related health issues, a rapidly aging population, and increased acknowledgment of snoring as a significant indicator of larger respiratory or sleep quality problems. The application of artificial intelligence, distance diagnostics, and custom technology opens new pathways for development. These factors together create an encouraging setting for future growth, making the U.S. market a key player ly for innovation, commercialization, and the use of advanced anti-snoring products.

US anti snoring devices by product is divided into mandibular advancement devices MADs, tongue stabilizing devices TSDs, continuous positive airway pressure CPAP devices, nasal devices, positional therapy devices, expiratory positive airway pressure EPAP devices and others. The market for anti-snoring devices in the United States features a varied array of products influenced by the nation’s interest in innovative, technology-connected, non-invasive solutions for sleep issues and a readiness to embrace new health technologies for consumers. Mandibular advancement devices, also known as MADs, are among the top categories in the U.S. This popularity is driven by the common practice of customization through dentists and a robust network of manufacturers that provide adjustable, heat-moldable, and precisely fitted alternatives. Tongue stabilizing devices, or TSDs, fill a slightly smaller but consistent niche, chosen by those who cannot handle mandibular repositioning yet need precise tongue control to stop airway blockage. Continuous Positive Airway Pressure machines, or CPAP devices, maintain a significant presence in the market due to the strong clinical infrastructure in the U.S., though they are often more associated with sleep apnea than with occasional snoring. Nasal devices including dilators, expanders, and designs targeting allergens thrive on the high occurrence of sinus issues and congestion-related snoring in America. Devices promoting positional therapy, particularly smart wearable bands and sensor-driven posture regulators, are increasingly preferred as U.S. consumers lean towards behavioral changes instead of mechanical fixes. Expiratory Positive Airway Pressure devices, or EPAP, are also gaining ground because of their compact, travel-accessible design and FDA-approved status, making them suitable for those after portable options. Additional categories, such as smart snoring monitors, vibration-based correctors, and combined oral-nasal systems, contribute to the variety seen in the U.S. market.

US anti snoring devices by type of snoring/indication is divided into primary snoring Simple Snoring and obstructive sleep apnea OSA-related snoring. The American market reveals a clearly segmented division between basic snoring aids and those intended for snoring due to obstructive sleep apnea. This distinction arises from medical differences and diagnostic methods driven by insurance. Basic snoring is frequently connected to aspects of lifestyle, nasal blockage, temporary airway constriction, or the way one sleeps. This area is heavily influenced by consumers, with a large presence of over-the-counter products. Items like nasal dilators, EPAP devices, simple mandibular advancement devices, and positional therapy instruments are commonly purchased without doctor oversight. These solutions attract individuals looking for quick fixes without going through formal sleep studies. In America, the culture promotes consumer choice, leading to significant expansion in this market sector, where online direct-to-consumer brands emphasize convenience, cost-effectiveness, and discreetness. On the other hand, snoring linked to obstructive sleep apnea OSA takes a more formal clinical approach in the U.S. This pathway is managed by sleep specialists and accredited institutions, using formal diagnostic methods like polysomnography or home sleep testing. Here, CPAP machines are prominent, supported by insurance providers dedicated to medically substantiated treatments for airway blockages. There is also a high demand for fitted mandibular advancement devices for OSA patients, particularly for those who cannot tolerate CPAP. The American healthcare system encourages doctors to view snoring from the perspective of long-term risks to heart health, metabolism, and cognitive function, thereby speeding up the adoption of devices as part of complete sleep treatment.

US anti snoring devices by distribution channel is divided into E-commerce/Online Platforms and other hypermarkets/supermarkets, specialty stores. Distribution pathways in the United States illustrate the nation’s interconnected healthcare system and advanced online shopping landscape, leading to various routes for product availability and significant consumer choice. Retail pharmacies and drugstores dominated by names like CVS, Walgreens, and Rite Aid represent a large portion of sales for main snoring solutions, providing nasal tools, over-the-counter oral devices, EPAP machines, and positional aids. Their extensive distribution in both urban and rural areas facilitates easy access and motivates impulsive purchases from those looking for immediate snoring solutions. Hospital systems and certified sleep clinics are crucial for distributing devices related to obstructive sleep apnea OSA in the U.S., especially for CPAP devices and dentist-recommended mandibular advancement tools. Medical channels benefit from reimbursement options, diagnostic supervision, follow-up adjustments for devices, and professional suggestions that coincide with long-term care strategies. Nevertheless, the most significant advancements have come from online shopping and direct-to-consumer websites. American DTC brands take advantage of subscription services, digital fitting instructions, smartphone-based monitoring applications, and the ease of home delivery. Online platforms also allow shoppers to compare different product options, read user feedback, and access fast shipping services all of which resonate with typical American shopping habits. While specialty shops and large retail outlets are smaller players, they also cater to consumers looking for easily obtainable, non-prescription snoring solutions. These pathways form a dynamic and adaptable distribution system.



Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031
Aspects covered in this report
• Anti-snoring Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By product
• Mandibular Advancement Devices (MADs)
• Tongue Stabilizing Devices (TSDs)
• Continuous Positive Airway Pressure (CPAP) Devices
• Nasal Devices
• Positional Therapy Devices
• Expiratory Positive Airway Pressure (EPAP) Devices
• Others

By Type of Snoring/Indication
• Primary Snoring (Simple Snoring)
• Obstructive Sleep Apnea (OSA)-Related Snoring

By Distribution Channel
• Retail Pharmacies & Drug Stores
• Hospital & Sleep Clinics
• E-commerce/Online Platforms (A rapidly growing segment due to DTC brands)
• Other (Hypermarkets/Supermarkets, Specialty Stores)